Bath & Body Works Stock Dips 2% Amid Mixed Earnings Report and Tepid Q1 Guidance: What Traders Should Know

Bath & Body Works (NYSE: BBWI) experienced a slight downturn in its stock price, slipping approximately 2% during Thursday's premarket session. This dip came on the heels of the retailer's disappointing forecast for the first quarter of fiscal 2025, which fell short of analysts' expectations.

For the fourth quarter of fiscal 2024, Bath & Body Works reported earnings per share (EPS) of $2.09, which surpassed the forecasted EPS of $2.04. The company also achieved a revenue total of $2.8 billion, exceeding the consensus estimate of $2.78 billion. Particularly notable were in-store sales in the U.S. and Canada, which hit $2.11 billion, outperforming the anticipated $2.08 billion. However, direct sales lagged behind projections, reaching $595 million against an expected $623.2 million. Additionally, international sales of $84 million did not meet the anticipated $89.1 million.

Despite these mixed results, the firm reported an operating income of $678 million for the fourth quarter, down by 2.6% from the previous year but still higher than the estimated $671.2 million. CEO Gina Boswell expressed optimism about the company’s performance, stating, "Our team delivered strong performance that exceeded expectations on both the top and bottom line in the critical fourth quarter. This success was fueled by our product innovation and the exceptional customer experience provided by our associates.” She added that the company is looking forward to capitalizing on its momentum as it moves into 2025.

Looking ahead, Bath & Body Works anticipates an EPS in the range of $0.36 to $0.43 for Q1 2025, falling short of analysts' expectations of $0.44. Revenue is projected to reach $1.384 billion, also lower than the consensus of $1.422 billion. For the year, the company forecasts an EPS between $3.25 and $3.60, slightly above the anticipated $3.26, while predicting revenues of $7.307 billion— marginally above the $7.295 billion estimate.

For traders, this mixed bag of quarterly results and tepid guidance introduces a level of uncertainty that could impact stock sentiment. As they weigh their options, they may want to consider how much of Bath & Body Works' performance relies on seasonal sales and whether the company's innovation and customer engagement strategies can help boost their numbers in challenging economic conditions. Keep an eye on this stock; the upcoming quarters will be critical for assessing whether BBWI is a resilient play or a bear in disguise.